Lightnews — Scholar-powered news

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · 7d

#IORjobs
Open positions in the Stem Cells and Cancer Lab, directed by Arianna Baggiolini:

- PhD Student: ior.usi.ch/events-news/...
- Lab Technician: ior.usi.ch/events-news/...

Apply now and join Baggiolini’s international and inspiring team!

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · 13d

#IORmoments
Many thanks to Prof. Markus Gerhard for today’s lecture in our PhD Lectures Serie!
We truly appreciated his time and the stimulating discussion with our community.

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · 20d

#IORnews
IOR study led by Prof. Catapano uncovers key mechanisms driving prostate cancer stem cells and paves the way for innovative therapies.

🔗Learn more: ior.usi.ch/events-news/...

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · 22d

🌐 The IOR Foundation has a brand-new website!
Discover more about our Foundation, which manages:
- our Institute, the IOR
- The International Extranodal Lymphoma Study Group (IELSG)
- The International Conference on Malignant Lymphoma (ICML)

🔗 www.foundationior.ch

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · 27d

#IORnews
The Lab of Prof. J.P. Theurillat together with Dr. M. Bolis created the Prostate Cancer Atlas, a web-based platform that empowers the research community to explore, compare, and analyze data with unprecedented ease and flexibility.

🔗 short-url.org/1ecu9

www.youtube.com/watch?v=qTjJ...

Prostate Cancer Atlas

YouTube video by Prostate Cancer Atlas

www.youtube.com

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Sep 9

#IORnews
A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL.

Learn more: tinyurl.com/ytybcbr8

1 2

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Aug 19

#IORnews
The Cancer Immunotherapy lab, led by Prof. A. Calcinotto, uncover a new immune–tumor interaction in ER+ breast cancer, opening the way for targeted therapies.

🔗Read more: ior.usi.ch/events-news/...

@calcinottolab.bsky.social

1 1

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Aug 7

#IORnews
Dr. Perez joins the IOR with a prestigious international grant on drug repurposing for healthy aging, now supported by the SNSF through the Money Follows Researcher agreement.

Read more: shorturl.at/pLKnm

1

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jul 18

#IORnews
Among the 32 projects selected for funding in the first half of 2025 by the Swiss Cancer Research Foundation, are 3 research projects from the IOR, led by Prof. A. Alimonti, Prof. F. Bertoni and Prof. D. Rossi, focusing on lymphoma and prostate cancer.

Read more: shorturl.at/xqmAd

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jul 5

Registration is open for the International Prostate Cancer Symposium (IPCS) 28–29 April 2026 – Lugano, Switzerland

Held just before APCCC 2026, IPCS is your chance to explore next-gen treatments & breakthrough research in prostate cancer care.

🔗Register now: apccc.org

1

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jul 4

#IORjobs
IOR invites applications from outstanding candidates interested in applying for the SNSF Ambizione and Marie Skłodowska-Curie Actions (MSCA) and EMBO fellowships.

⏳ IOR internal deadline: 3 August 2025

➡️ Details & application procedure: shorturl.at/caVdu

1 1

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jul 3

#IORnews
New study from Prof. Jean-Philippe Theurillat’s Lab maps proteomic changes in prostate cancer progression, revealing overlooked drivers of aggressiveness.

🔗 Read the news: shorturl.at/wZWou

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jul 2

The annual meeting of the Bellinzona Institutes of Science (Bios+) association, composed of the IOR and the Institute for Research in Biomedicine, took place on 4 June in Bellinzona.
During the meeting, atty. G. Gendotti was appointed as the new Bios+ President.

biosplus.ch/news-press/2...

Bios⁺ - Bios+: Atty. Gabriele Gendotti appointed President

Bellinzona Institutes of Science (Bios⁺) is a non-profit association aiming to promote, support and coordinate the scientific research and teaching activities of its members in view of the establishme...

biosplus.ch

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jun 26

The Foundation for the IOR is deeply saddened by the sudden passing of Prof. Esteban Cvitkovic on June 20, 2025.
A passionate supporter of our Institute and, until recently, a highly active member of our Scientific Advisory Board, he played a key role in shaping our research.

🔗 shorturl.at/QSUKp

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jun 21

#IORnews
The 18th edition of the International Conference on Malignant Lymphoma (18-ICML), one of the most prestigious global events dedicated to lymphoid malignancies, concludes today after a week of intense scientific exchange and groundbreaking presentations.

🔗 ior.usi.ch/events-news/...

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jun 20

#IORnews
🏆 Prof. F. Cavalli, President of the IOR Foundation, has been selected as the 2025 inductee in the Lymphoma category by the Giants of Cancer Care program, a prestigious recognition that honors the world’s most distinguished cancer researchers and clinicians.

➡️ Read more: shorturl.at/j7dbB

1

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jun 16

#IORnews
A Swiss study led by Prof. Davide Rossi opens the door to a new opportunity for patients with relapsed chronic lymphocytic leukemia.

📄 Read more: shorturl.at/bokQS

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jun 12

𝗖𝗼𝗿𝘀𝗮 𝗱𝗲𝗹𝗹𝗮 𝗦𝗽𝗲𝗿𝗮𝗻𝘇𝗮 returns to Lugano on June 15, 2025, to celebrate 20 years of solidarity and movement for cancer research.

We encourage you to participate in this meaningful event, because every step counts!

👉 See lnkd.in/gpa3cH29 for details about the programme and registration.

1 1

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jun 10

The countdown for the IBSA Foundation Forum is on – don’t miss it on 30 June 2025!

More info: www.linkedin.com/posts/ibsa-f...

#ibsafoundation #forum #scientificforum #aging #healthyaging… | IBSA Foundation for scientific research

⏳ Less than one month left! On 30 June 2025, IBSA Foundation is proud to host a new edition of its scientific forum: “Senotherapeutics Revolution: Transforming Aging and Cancer Therapy” 📍 Join us fr...

www.linkedin.com

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Jun 5

#IORjobs

Open PhD Position!
Join Arianna Baggiolini @ariannabaggiolini.bsky.social ’s Lab to work on human pluripotent stem cell (hPSC)-based models of the peripheral nervous system and disease.

Info and application: ior.usi.ch/events-news/...

2 1

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · May 26

#IORnews

🎉 Congratulations to Dr. Bianca Calì, research associate in our Molecular Oncology Lab, for receiving the prestigious SAKK/Astellas GU-Oncology Award 2025!

➡️ Discover more about her winning study: shorturl.at/N2UaB

1

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · May 23

#IORnews
Jonas Van Lent receives the Children's Tumor Foundation's Young Investigator Award. Congrats @jonasvanlent.bsky.social !

Read more: shorturl.at/ObLS5

3 2

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Apr 17

The IOR is glad to host the SYIS Seminar today at 5PM CET, with Arianna Calcinotto as speaker.

You can still join us in person or online via Zoom (check the image below for connection details).

CalcinottoLab @calcinottolab.bsky.social · Apr 16

Bellinzona is ready to host the next SYIS seminar on April 17!
I’m excited to join the event as a speaker, alongside Christian Pasquali from OM Pharma.
Join us at 5:00 pm (CET) — either in person in Bellinzona or online via Zoom!

1

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Apr 11

#IORnews
IOR researchers uncover a new mechanism linking senescent cells and immune suppression in prostate cancer, paving the way for improved therapies.

➡️ Discover more: shorturl.at/7PBJ0

2

Institute of Oncology Research (IOR) @iorbellinzona.bsky.social · Apr 11

#IORnews
🧬 New bioinformatic tool developed at IOR: EasyCircR. This open-source R package maps circRNA-miRNA-mRNA interactions, unlocking insights into gene regulation & cancer research.

Discover more: shorturl.at/xjizN

2